Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

Adolescent Tdap vaccine use among primary care physicians.

Dempsey AF, Cowan AE, Broder KR, Kretsinger K, Stokley S, Clark SJ.

J Adolesc Health. 2009 Apr;44(4):387-93. doi: 10.1016/j.jadohealth.2008.08.019. Epub 2008 Nov 7.

PMID:
19306798
2.

Physician attitudes and preferences about combined Tdap vaccines for adolescents.

Davis MM, Broder KR, Cowan AE, Mijalski C, Katrina K, Stokley S, Clark SJ.

Am J Prev Med. 2006 Aug;31(2):176-80.

PMID:
16913066
3.

New combined tetanus-diptheria-acellular pertussis vaccines for adults: primary care physician attitudes and preferences.

Davis MM, Kretsinger K, Cowan AE, Stokley S, Clark SJ.

Hum Vaccin. 2007 Jul-Aug;3(4):130-4. Epub 2007 Apr 8.

PMID:
17643067
4.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
5.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.

6.

Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1302-6.

7.

Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases.

Talbird SE, Graham J, Mauskopf J, Masseria C, Krishnarajah G.

J Manag Care Spec Pharm. 2015 Jan;21(1):88-99, 99a-c.

8.
9.

Pertussis infection in the United States: role for vaccination of adolescents and adults.

Brooks DA, Clover R.

J Am Board Fam Med. 2006 Nov-Dec;19(6):603-11.

10.

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.

Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR.

Pediatrics. 2006 Apr;117(4):1084-93.

PMID:
16585302
11.

National vaccination coverage among adolescents aged 13-17 years--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Aug 31;56(34):885-8.

12.

Timing of adolescent meningococcal conjugate vaccination attitudes and practices of pediatricians and family medicine physicians.

Allison MA, Cohn AC, Stokley S, Crane LA, O'Leary ST, Hurley LP, Babbel CI, Dong F, Gahm C, Temte JL, Kempe A.

Am J Prev Med. 2011 Dec;41(6):581-7. doi: 10.1016/j.amepre.2011.08.007.

PMID:
22099234
13.

Vaccination coverage among adolescents aged 13-17 years - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3. Erratum in: MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):10.

14.

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jun 29;61(25):468-70. Erratum in: MMWR Morb Mortal Wkly Rep. 2012 Jul 13;61(27):515.

15.

Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Jul 25;57(29):796-9.

16.

Predictors of tetanus-diphtheria- acellular pertussis vaccination among adults receiving tetanus vaccine in the United States: data from the 2008 national health interview survey.

Johns TL, Roetzheim R, Chen R.

J Prim Care Community Health. 2013 Apr 1;4(2):95-100. doi: 10.1177/2150131912455428. Epub 2012 Aug 1.

PMID:
23799715
17.

Physician perspectives to inform a new recommendation for meningococcal conjugate vaccine (MCV4).

Clark SJ, Cowan AE, Stokley S, Bilukha O, Davis MM.

J Adolesc Health. 2006 Dec;39(6):850-5.

PMID:
17116515
18.

Notes from the field : use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an Emergency Department - Arizona, 2009-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):55-6.

19.

Economic considerations for pertussis booster vaccination in adolescents.

Hay JW, Ward JI.

Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S127-33. Review.

PMID:
15931140
20.

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

Halperin SA, Sweet L, Baxendale D, Neatby A, Rykers P, Smith B, Zelman M, Maus D, Lavigne P, Decker MD.

Pediatr Infect Dis J. 2006 Mar;25(3):195-200.

PMID:
16511379

Supplemental Content

Support Center